Estradiol Deferiprone Tablets, which is a combination formulation containing estrogen and progestin, is mainly used for the treatment of perimenopausal syndrome due to natural or postoperative menopause. Estradiol Deferiprone Tablets are packaged in a combination with Estradiol Tablets for the clinical treatment of perimenopausal syndrome due to natural or postoperative menopause. Its dosage: 28 days as a treatment cycle, 1 tablet per day. Estradiol tablets are taken for the first 14 days and estradiol digestrol tablets for the last 14 days. In the treatment of menopause-related symptoms, the lowest dose is recommended for the shortest course of treatment. During use, attention is paid to individual adjustment of the dose administered according to the clinical outcome of treatment. Estradiol Didroxyprogesterone Tablets and Estradiol Tablets are not affected by food when administered. There are many adverse reactions, mainly including, gastrointestinal reactions: nausea, abdominal pain and flatulence are common; infections and infectious diseases: vaginal candidiasis is occasionally seen; neurological diseases: headache and migraine are common, dizziness is occasionally seen, chorea is rare; systemic diseases and administration site reactions: weakness is common, peripheral edema is occasionally seen; reproductive system and breast diseases: breast pain, distension symptoms and other adverse reactions may occur . Estradiol Tablets and Estradiol Digestrol Tablets sequential hormone replacement therapy for the treatment of perimenopausal syndrome due to natural or postoperative menopause. For specific medication, please refer to the clinical situation and be guided by the doctor’s interview.